Follow this preprint

Immunogenicity and safety of a recombinant adenovirus type-5 COVID-19 vaccine in adults: data from a randomised, double-blind, placebo-controlled, single-dose, phase 3 trial in Russia

Dmitry Lioznov, Irina Amosova, Savely A. Sheetikov, Ksenia V. Zornikova, Yana Serdyuk, Grigory A. Efimov, Mikhail Tsyferov, Mikhail Khmelevskii, Andrei Afanasiev, Nadezhda Khomyakova, Dmitry Zubkov, Anton Tikhonov, Tao Zhu, Luis Barreto, Vitalina Dzutseva
doi: https://doi.org/10.1101/2022.03.01.22271507

Article Information

doi 
https://doi.org/10.1101/2022.03.01.22271507
History 
  • March 11, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Dmitry Lioznov1,2,
  2. Irina Amosova1,
  3. Savely A. Sheetikov3,
  4. Ksenia V. Zornikova3,
  5. Yana Serdyuk3,
  6. Grigory A. Efimov3,
  7. Mikhail Tsyferov4,
  8. Mikhail Khmelevskii4,
  9. Andrei Afanasiev4,
  10. Nadezhda Khomyakova4,
  11. Dmitry Zubkov4,
  12. Anton Tikhonov4,
  13. Tao Zhu5,
  14. Luis Barreto5 and
  15. Vitalina Dzutseva4,6,*
  1. 1Smorodintsev Research Institute of Influenza, St Petersburg, Russia
  2. 2Department of Infectious Diseases and Epidemiology, First Pavlov State Medical University, St. Petersburg, Russia
  3. 3National Research Center for Hematology, Moscow, Russia
  4. 4NPO Petrovax Pharm LLC, Moscow, Russia
  5. 5CanSino Biologics Inc., Tianjin, China
  6. 6Novosibirsk State University, Medical School, Novosibirsk, Russia
  1. ↵*Corresponding author: E-mail: DzutsevaVV{at}petrovax.ru (VD)
Back to top
Posted March 11, 2022.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML

Supplementary Material

Data/Code
Email
Immunogenicity and safety of a recombinant adenovirus type-5 COVID-19 vaccine in adults: data from a randomised, double-blind, placebo-controlled, single-dose, phase 3 trial in Russia
Dmitry Lioznov, Irina Amosova, Savely A. Sheetikov, Ksenia V. Zornikova, Yana Serdyuk, Grigory A. Efimov, Mikhail Tsyferov, Mikhail Khmelevskii, Andrei Afanasiev, Nadezhda Khomyakova, Dmitry Zubkov, Anton Tikhonov, Tao Zhu, Luis Barreto, Vitalina Dzutseva
medRxiv 2022.03.01.22271507; doi: https://doi.org/10.1101/2022.03.01.22271507
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

0

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

0

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.